Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2015

01-12-2015 | Case Report

A case of exogenous corticosteroid-induced Kaposi’s sarcoma that developed after a cure of endogenous hypercortisolism

Authors: Soyeon Yoo, Shinhang Moon, Sang-Ouk Chin, Sang-Ah Lee, Changlim Hyun, Gwanpyo Koh

Published in: International Journal of Clinical Pharmacy | Issue 6/2015

Login to get access

Abstract

Case Kaposi’s sarcoma (KS) is a malignant vascular tumor that occurs commonly in patients with acquired immunodeficiency syndrome. KS associated with Cushing’s syndrome (CS) is unusual, especially in endogenous CS. Here, we report a case of KS associated with glucocorticoid-replacement therapy after surgical treatment for adrenal CS. A 70-year-old man presented with symptoms and signs of CS with a left adrenal mass. Adrenal CS was confirmed by biochemical studies. After left adrenalectomy, he took oral prednisolone (15 mg/day) to prevent adrenal insufficiency. Ten weeks later, numerous raised purple plaques on the lower extremities were newly detected. The biopsy findings were compatible with KS, but anti-HIV antibodies were negative. After withdrawal of glucocorticoid therapy, the skin lesions regressed completely. Conclusion In this case, KS developed after the use of exogenous corticosteroid but not during endogenous hypercortisolism. This finding suggests that endogenous and exogenous corticosteroid play different roles in the development of KS.
Literature
1.
go back to reference Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi’s sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol. 1993;28(3):371–95.CrossRefPubMed Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi’s sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol. 1993;28(3):371–95.CrossRefPubMed
3.
go back to reference Nassar D, Schartz NE, Bouche C, Levy A, Kerob D, Agbalika F, et al. Kaposi’s sarcoma after long-acting steroids: time until remission and drug washout. Dermatology. 2010;220(2):159–63.CrossRefPubMed Nassar D, Schartz NE, Bouche C, Levy A, Kerob D, Agbalika F, et al. Kaposi’s sarcoma after long-acting steroids: time until remission and drug washout. Dermatology. 2010;220(2):159–63.CrossRefPubMed
4.
go back to reference Bragado L, Ruiz Gutierrez L, Cuende E, Lopez Gonzalez JL. Kaposi’s sarcoma in a steroid-treated antisynthethase antibody syndrome patient. Reumatol Clin. 2013;9(4):243–5.CrossRefPubMed Bragado L, Ruiz Gutierrez L, Cuende E, Lopez Gonzalez JL. Kaposi’s sarcoma in a steroid-treated antisynthethase antibody syndrome patient. Reumatol Clin. 2013;9(4):243–5.CrossRefPubMed
5.
go back to reference Bala M, Ronchi CL, Pichl J, Wild V, Kircher S, Allolio B, et al. Suspected metastatic adrenocortical carcinoma revealing as pulmonary Kaposi sarcoma in adrenal Cushing’s syndrome. BMC Endocr Disord. 2014;14:63.PubMedCentralCrossRefPubMed Bala M, Ronchi CL, Pichl J, Wild V, Kircher S, Allolio B, et al. Suspected metastatic adrenocortical carcinoma revealing as pulmonary Kaposi sarcoma in adrenal Cushing’s syndrome. BMC Endocr Disord. 2014;14:63.PubMedCentralCrossRefPubMed
6.
go back to reference Zavos G, Bokos J, Papaconstantinou I, Boletis J, Gazouli M, Kakisis J, et al. Clinicopathological aspects of 18 Kaposi’s sarcoma among 1055 Greek renal transplant recipients. Artif Organs. 2004;28(6):595–9.CrossRefPubMed Zavos G, Bokos J, Papaconstantinou I, Boletis J, Gazouli M, Kakisis J, et al. Clinicopathological aspects of 18 Kaposi’s sarcoma among 1055 Greek renal transplant recipients. Artif Organs. 2004;28(6):595–9.CrossRefPubMed
7.
go back to reference Gill PS, Loureiro C, Bernstein-Singer M, Rarick MU, Sattler F, Levine AM. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Int Med. 1989;110(11):937–40.CrossRefPubMed Gill PS, Loureiro C, Bernstein-Singer M, Rarick MU, Sattler F, Levine AM. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Int Med. 1989;110(11):937–40.CrossRefPubMed
8.
go back to reference Guo WX, Antakly T. AIDS-related Kaposi’s sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am J Pathol. 1995;146(3):727–34.PubMedCentralPubMed Guo WX, Antakly T. AIDS-related Kaposi’s sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am J Pathol. 1995;146(3):727–34.PubMedCentralPubMed
9.
go back to reference Hudnall SD, Rady PL, Tyring SK, Fish JC. Hydrocortisone activation of human herpesvirus 8 viral DNA replication and gene expression in vitro. Transplantation. 1999;67(5):648–52.CrossRefPubMed Hudnall SD, Rady PL, Tyring SK, Fish JC. Hydrocortisone activation of human herpesvirus 8 viral DNA replication and gene expression in vitro. Transplantation. 1999;67(5):648–52.CrossRefPubMed
10.
go back to reference Zoeteweij JP, Rinderknecht AS, Davis DA, Yarchoan R, Blauvelt A. Minimal reactivation of Kaposi’s sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines. J Med Virol. 2002;66(3):378–83.CrossRefPubMed Zoeteweij JP, Rinderknecht AS, Davis DA, Yarchoan R, Blauvelt A. Minimal reactivation of Kaposi’s sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines. J Med Virol. 2002;66(3):378–83.CrossRefPubMed
Metadata
Title
A case of exogenous corticosteroid-induced Kaposi’s sarcoma that developed after a cure of endogenous hypercortisolism
Authors
Soyeon Yoo
Shinhang Moon
Sang-Ouk Chin
Sang-Ah Lee
Changlim Hyun
Gwanpyo Koh
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0181-5

Other articles of this Issue 6/2015

International Journal of Clinical Pharmacy 6/2015 Go to the issue